Evaluating hyperbaric oxygen therapy as an adjunct... (2025 study) Skip to main content
Meta-Analysis European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - 2025

Evaluating hyperbaric oxygen therapy as an adjunct to corticosteroids in sudden sensorineural hearing loss: a systematic review and meta-analysis.

Moghib K, Dawoud ALA, Altalab G, Syed MS, Salomon I, Musse HAY, et al., European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - , 2025

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers combined results from multiple randomized trials to see whether adding hyperbaric oxygen therapy to standard steroid treatment helps people recover hearing after sudden sensorineural hearing loss.

What They Found

This systematic review and meta-analysis of 14 randomized controlled trials with 794 participants found that combining hyperbaric oxygen therapy with systemic corticosteroids significantly improved low-frequency hearing thresholds (standardized mean difference: 0.83, 95% CI: 0.66-1.00, p less than 0.0001) and increased the odds of complete hearing recovery (odds ratio: 2.05, 95% CI: 1.41-2.98, p equals 0.0002) compared with corticosteroids alone. However, the studies showed significant heterogeneity (I squared equals 96.7%) and variation in treatment protocols. Mild adverse events, including vertigo, were reported. The authors note that high heterogeneity and a lack of statistical significance in the random-effects model call for cautious interpretation of these findings.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The meta-analysis showed very high heterogeneity between included trials (I squared equals 96.7%) and variation in treatment protocols, and the authors themselves state that the lack of statistical significance in the random-effects model calls for cautious interpretation, with well-designed, standardized RCTs still needed to confirm the findings.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Meta-Analysis
Category Sudden Hearing Loss
Source Pubmed
PubMed ID 40405024
Year Published 2025
Journal European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology -
MeSH Terms Humans; Hyperbaric Oxygenation; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Combined Modality Therapy; Adrenal Cortex Hormones; Randomized Controlled Trials as Topic; Treatment Outcome

Cite This Study

Share

This study relates to Sudden Sensorineural Hearing Loss. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Sudden Hearing Loss

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology